BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Li X, Li X, Ding L. Comprehensive Analysis to Identify Enhancer-Regulated Inflammation-Associated Genes in Lung Adenocarcinoma. Cancer Manag Res 2021;13:7115-29. [PMID: 34539188 DOI: 10.2147/CMAR.S317922] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
Number Citing Articles
1 Chen K, Ye C, Gao Z, Hu J, Chen C, Xiao R, Lu F, Wei K. Immune infiltration patterns and identification of new diagnostic biomarkers GDF10, NCKAP5, and RTKN2 in non-small cell lung cancer. Transl Oncol 2023;29:101618. [PMID: 36628881 DOI: 10.1016/j.tranon.2023.101618] [Reference Citation Analysis]
2 Shao F, Mao H, Luo T, Li Q, Xu L, Xie Y. HPGDS is a novel prognostic marker associated with lipid metabolism and aggressiveness in lung adenocarcinoma. Front Oncol 2022;12:894485. [DOI: 10.3389/fonc.2022.894485] [Reference Citation Analysis]
3 Cheng B, Wang Y, Ayanlaja AA, Zhu J, Kambey PA, Qiu Z, Zhang C, Hu W. Glutathione S-Transferases S1, Z1 and A1 Serve as Prognostic Factors in Glioblastoma and Promote Drug Resistance through Antioxidant Pathways. Cells 2022;11:3232. [PMID: 36291099 DOI: 10.3390/cells11203232] [Reference Citation Analysis]
4 Chen W, Guo Z, Wu J, Lin G, Chen S, Lin Q, Yang J, Xu Y, Zeng Y. Identification of a ZC3H12D-regulated competing endogenous RNA network for prognosis of lung adenocarcinoma at single-cell level. BMC Cancer 2022;22. [DOI: 10.1186/s12885-021-08992-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]